NasdaqCM - Nasdaq Real Time Price USD
Dyadic International, Inc. (DYAI)
1.2457
+0.0457
+(3.81%)
As of 9:47:31 AM EDT. Market Open.
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 8.92M | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| KAYE JACK Director | Conversion of Exercise of derivative security at price 1.33 per share. | Direct | 39,900 | Mar 5, 2025 |
| HERBST SETH J. M.D. Director | Conversion of Exercise of derivative security at price 0.97 per share. | Direct | 24,250 | Jan 6, 2025 |
| KAYE JACK Director | -- | Direct | -- | Jan 2, 2025 |
| TARNOK MICHAEL P Director | -- | Direct | -- | Jan 2, 2025 |
| LUCY PATRICK K Director | -- | Direct | -- | Jan 2, 2025 |
| BOSE ARINDAM Director | -- | Direct | -- | Jan 2, 2025 |
| HERBST SETH J. M.D. Director | -- | Direct | -- | Jan 2, 2025 |
| EMALFARB MARK A Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 2, 2025 |
| RAWSON PING WANG Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 2, 2025 |
| TCHELET RONEN Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 2, 2025 |
| HAZELTON JOSEPH P Chief Operating Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 2, 2025 |
| TARNOK MICHAEL P Director | Conversion of Exercise of derivative security at price 0.97 per share. | Direct | 24,250 | Nov 22, 2024 |
| BUCKLAND BARRY JOHN Director | -- | Direct | -- | Jun 11, 2024 |
| TARNOK MICHAEL P Director | Conversion of Exercise of derivative security at price 1.36 per share. | Direct | 40,800 | May 21, 2024 |
| EMALFARB MARK A Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 13, 2024 |
| RAWSON PING WANG Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 13, 2024 |
| TCHELET RONEN Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 13, 2024 |
| HAZELTON JOSEPH P Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 13, 2024 |
| KAYE JACK Director | -- | Direct | -- | Jan 3, 2024 |
| TARNOK MICHAEL P Director | -- | Direct | -- | Jan 3, 2024 |
| LUCY PATRICK K Director | -- | Direct | -- | Jan 3, 2024 |
| BUCKLAND BARRY JOHN Director | -- | Direct | -- | Jan 3, 2024 |
| BOSE ARINDAM Director | -- | Direct | -- | Jan 3, 2024 |
| HERBST SETH J. M.D. Director | -- | Direct | -- | Jan 3, 2024 |
Related Tickers
MCET MultiCell Technologies, Inc.
0.0000
0.00%
QBIO Q BioMed Inc.
0.0001
0.00%
WXXWY WuXi Biologics (Cayman) Inc.
5.81
+0.17%
THAR Tharimmune, Inc.
1.2800
+3.23%
EXOZ eXoZymes, Inc.
12.43
-8.13%
RNTX Rein Therapeutics Inc.
1.9100
+4.95%
ACTU Actuate Therapeutics, Inc. Common stock
8.82
-2.00%
BRTX BioRestorative Therapies, Inc.
1.7146
-0.89%
ORGS Orgenesis Inc.
2.4900
+12.67%
PMVP PMV Pharmaceuticals, Inc.
1.0600
-0.93%